Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Feb 28, 2016; 22(8): 2576-2584
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2576
Table 2 Pathological characteristics and follow-up results of 469 rectal adenocarcinoma patients n (%)
CharacteristicTotal patient s(n = 469)1RAC patients with LNM (n = 231)1RAC patients without LNM (n = 238)1P value
Pathological lymph node stage< 0.001
pN0238 (50.7)0 (0.0)238 (100.0)-
pN1136 (29.0)136 (58.9)0 (0.0)-
pN295 (20.3)95 (41.1)0 (0.0)-
Pathological tumor classification (pT)< 0.001
pT118 (3.8)1 (0.4)17 (7.1)-
pT290 (19.2)21 (9.1)69 (29.0)-
pT3118 (25.2)54 (23.4)64 (26.9)-
pT4243 (51.8)155 (67.1)88 (37.0)-
Pathological distant metastasis (pM)
pM0439 (93.6)213 (92.2)226 (95.0)0.224
pM130 (6.4)18 (7.8)12 (5.0)-
Tumor differentiation
Moderately/well388 (82.7)166 (71.9)222 (93.3)< 0.001
Poorly57 (12.2)46 (19.9)11 (4.6)-
Unknown24 (5.1)19 (8.2)5 (2.1)-
Number of lymph node
Lymph node-positive (metastasis)2.2 ± 4.54.5 ± 5.5--
Total number of lymph node removal13.3 ± 8.415.0 ± 9.111.6 ± 7.3< 0.001
Results of follow-up
Death72 (15.4)46 (19.9)26 (10.9)0.007
Survival277 (59.1)118 (51.1)159 (66.8)0.001
Lost120 (25.6)67 (29.0)53 (22.3)0.095
Time of follow-up2 (mo)24.0 (9.0-44.3)20 (9.0-37.9)29.1 (10.5-48.5)0.013